Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


26.11.2018

1 BMJ
2 Eur J Gastroenterol Hepatol
1 Gastroenterol Hepatol
1 Gastroenterology
2 J Hepatol
2 J Infect Dis
4 J Viral Hepat
1 J Virol
1 PLoS One
1 PLoS Pathog
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMJ

  1. HAWKES N
    Hepatitis C: NHS seeks to identify 55 000 patients for treatment.
    BMJ. 2018;363:k4923.
    PubMed     Text format    


    Eur J Gastroenterol Hepatol

  2. LYBECK C, Brenndorfer ED, Sallberg M, Montgomery SM, et al
    Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patients.
    Eur J Gastroenterol Hepatol. 2018 Nov 19. doi: 10.1097/MEG.0000000000001316.
    PubMed     Text format     Abstract available

  3. DEMERDASH HM, Elyamany AS, Arida E
    Impact of direct-acting antivirals on leukocytic DNA telomere length in hepatitis C virus-related hepatic cirrhosis.
    Eur J Gastroenterol Hepatol. 2018 Nov 15. doi: 10.1097/MEG.0000000000001306.
    PubMed     Text format     Abstract available


    Gastroenterol Hepatol

  4. ALSIUS M, Ferri MJ, Buxo M, Lopez C, et al
    Autoantibodies to cytoplasmic rods and rings in patients with hepatitis C virus infection treated with direct-acting antivirals: The role of prior treatment with interferon plus ribavirin.
    Gastroenterol Hepatol. 2018 Nov 13. pii: S0210-5705(18)30249.
    PubMed     Text format     Abstract available


    Gastroenterology

  5. BUTT AA, Yan P, Shuaib A, Abou-Samra AB, et al
    Direct-acting Antiviral Therapy for HCV Infection is Associated with a Reduced Risk of Cardiovascular Disease Events.
    Gastroenterology. 2018 Nov 13. pii: S0016-5085(18)35264.
    PubMed     Text format     Abstract available


    J Hepatol

  6. TRIVEDI PJ, Hubscher SG, Heneghan M, Gleeson D, et al
    Grand Round: Autoimmune Hepatitis.
    J Hepatol. 2018 Nov 19. pii: S0168-8278(18)32538.
    PubMed     Text format     Abstract available

  7. STAMM LM, Brainard DM, McHutchison JG
    Sofosbuvir/Velpatasvir for Patients with Chronic Genotype 3 HCV Infection with Compensated Cirrhosis: Response to EASL Recommendations on Treatment of Hepatitis C 2018.
    J Hepatol. 2018 Nov 13. pii: S0168-8278(18)32528.
    PubMed     Text format    


    J Infect Dis

  8. YEH ML, Huang CI, Huang CF, Hsieh MH, et al
    Pretreatment Hepatitis B Viral Load Predicts Long-term Hepatitis B Response after Anti-hepatitis C Therapy in Hepatitis B/C Dual-infected Patients.
    J Infect Dis. 2018 Nov 19. pii: 5191105. doi: 10.1093.
    PubMed     Text format     Abstract available

  9. PRICE JC, McKinney JE, Crouch PC, Dillon SM, et al
    Sexually Acquired Hepatitis C Infection in HIV-uninfected Men Who Have Sex with Men Using Pre-exposure Prophylaxis Against HIV.
    J Infect Dis. 2018 Nov 20. pii: 5193510. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Viral Hepat

  10. HOLMES JA, Carlton-Smith C, Kim AY, Dumas EO, et al
    Dynamic Changes in Innate Immune Responses During Direct Acting Antiviral Therapy for HCV Infection.
    J Viral Hepat. 2018 Nov 19. doi: 10.1111/jvh.13041.
    PubMed     Text format     Abstract available

  11. MIJOCEVIC H, Karimzadeh H, Seebach J, Usman Z, et al
    Variants of hepatitis B virus surface antigen observed during therapy with nucleic acid polymer REP 2139-Ca have no influence on treatment outcome and its detection by diagnostic assays.
    J Viral Hepat. 2018 Nov 19. doi: 10.1111/jvh.13044.
    PubMed     Text format     Abstract available

  12. KAPILA N, Flocco G, Al Khalloufi K, Zervos XB, et al
    Transplantation of kidneys from HCV viremic donors to HCV viremic recipients followed by early direct acting anti-viral therapy without ribavirin.
    J Viral Hepat. 2018 Nov 18. doi: 10.1111/jvh.13042.
    PubMed     Text format     Abstract available

  13. BUTT ZA, Mak S, Gesink D, Gilbert M, et al
    Applying core theory and spatial analysis to identify Hepatitis C Virus infection 'core areas' in British Columbia, Canada.
    J Viral Hepat. 2018 Nov 17. doi: 10.1111/jvh.13043.
    PubMed     Text format     Abstract available


    J Virol

  14. CAPELLI N, Marion O, Dubois M, Allart S, et al
    Vectorial Release of Hepatitis E Virus in Polarized Human Hepatocytes.
    J Virol. 2018 Nov 21. pii: JVI.01207-18. doi: 10.1128/JVI.01207.
    PubMed     Text format     Abstract available


    PLoS One

  15. INOUE T, Ito Y, Nishizawa N, Eshima K, et al
    RAMP1 in Kupffer cells is a critical regulator in immune-mediated hepatitis.
    PLoS One. 2018;13:e0200432.
    PubMed     Text format     Abstract available


    PLoS Pathog

  16. LIANG Y, Cao X, Ding Q, Zhao Y, et al
    Correction: Hepatitis C virus NS4B induces the degradation of TRIF to inhibit TLR3-mediated interferon signaling pathway.
    PLoS Pathog. 2018;14:e1007455.
    PubMed     Text format     Abstract available


    Vaccine

  17. NAGASHIMA S, Yamamoto C, Ko K, Chuon C, et al
    Acquisition rate of antibody to hepatitis B surface antigen among medical and dental students in Japan after three-dose hepatitis B vaccination.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31541.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: